INDIRECT COSTS OF COMMON COLD IN GERMANY

Author(s)

Franz P Hessel, MD, MPH, Research Fellow, Jürgen Wasem, MBA, Professor University of Duisburg-Essen, Essen, Germany

OBJECTIVES: To estimate the indirect costs caused by productivity loss due to simple infections of the upper respiratory tract in Germany. METHODS: A representative sample of the working population defined by membership in the social insurance in Germany (n = 994) was interviewed concerning the annual incidence, work-off days and days at work with limited productivity. The sample was representative concerning age, sex and social status, and stratified by age, sex, region (eastern and western part of Germany) and working status e.g. employee, worker, trainee etc. Productivity losses were valued using the human capital approach (HC) and the friction cost method (FC). Data were extracted from different German administrative sources like the federal institute for statistics. RESULTS: The mean number of work-off days was 2.9d. At 11.6d per year the productivity was limited by 35% due to a cold. The total annual productivity loss per person was 7d. The mean costs per working person were €1009 (HC) respectively €807 (FC) using stratified mean incomes of year 2004. Aggregated to the total working population of Germany the indirect costs of illness in 2004 were about 29.2 billion € (HC) respectively 23.3 billion € (FC). There was a clear trend to lower cost in men and in younger age groups. CONCLUSIONS: Although the direct medical costs per person for the treatment of common cold without complications are low, the high incidence of the disorder induces impressively high indirect costs caused by short-time work-off and a relevant number of days at work with a limited productivity due to a cold.

Conference/Value in Health Info

2006-10, ISPOR Europe 2006, Copenhagen, Denmark

Value in Health, Vol. 9, No.6 (November/December 2006)

Code

PMC5

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×